Model Number DTMB1D4 |
Device Problem
Pacing Problem (1439)
|
Patient Problems
Tachycardia (2095); Syncope/Fainting (4411)
|
Event Date 03/30/2024 |
Event Type
Injury
|
Event Description
|
It was reported that the patient experienced ventricular tachycardia (vt) and syncope.The right atrial (ra) lead exhibited undersensing on the current and stored electrograms (egm).It was noted that the cardiac resynchronization therapy defibrillator (crt-d) was not working and not pacing.The ra lead and crt-d remain in use. no further patient complications have been reported as a result of this event.
|
|
Manufacturer Narrative
|
Continuation of d10: 6935m55 lead implanted: (b)(6) 2022.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
Manufacturer Narrative
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
Manufacturer Narrative
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
Event Description
|
It was further reported that the lack of pacing was due to the patient presenting with vt.It was noted that the syncope was secondary to sustained vt and not related to a product performance issue.It was further noted that therapies were programmed off as the patient was transferred to hospice care.
|
|
Search Alerts/Recalls
|